With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...
Hosted on MSN11mon
In a future with more ‘mind reading,’ thanks to neurotech, we may need to rethink freedom of thoughtNeurotech represents a new threat to our ability ... can be used to measure changes in blood flow in the brain and produce images of that activity. Artificial intelligence can then analyze those ...
Gene therapy offers one-time treatment, but must also be administered by injection. Neurotech Pharmaceuticals’ gene therapy comes in a surgical implant, and it’s now the first FDA-approved ...
Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia type 2 (MacTel), a rare eye disease leading to progressive and ...
CUMBERLAND, R.I., March 06, 2025--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced ...
Neurotech Pharmaceuticals Inc., whose executive chairman is well-known Orange County executive Jim Mazzo, announced that it received FDA approval for its treatment of a type of macular telangiectasia ...
But not this time. Community Health Center of Buffalo, which provides health care to underserved populations, has partnered with Cerebro NeuroTech, a Buffalo-based company that specializes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback